FDA clears Lannett's oxycodone

The FDA approves Lannett Company's (LCI +4.1%) generic oxycodone 5 mg. Product shipments will commence in the next several months.

Related tickers: (ZGNX -4.3%) (TEVA -0.5%) (MNK +0.3%) (ALKS -0.6%)

From other sites
Comments (1)
  • Wall Street Sleuth
    , contributor
    Comments (100) | Send Message
    Why is ZGNX mentioned? Zohydro is the only long term pain drug without acetaminophen. Short sellers are throwing everything at ZGNX to shake loose hands.
    4 Aug 2014, 07:26 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs